zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2022 / A Hongkong patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

A Hongkong patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

2022-01-11

Published Date:2022-01-11

Original Link:https://www.onenessbio.com/en/news_detail136_4.htm

No 1 Date of announcement 2022/01/11 Time of announcement 17:00:43
Subject A Hongkong patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.
To which item it meets paragraph 53 Date of events 2022/01/11
Statement
  1. Date of occurrence of the event:2022/01/11
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or  ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:
    The Company has been informed by the patent agency that a Hongkong patent titled ”USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted under the patent number HK1237251.
  6. Countermeasures:None
  7. Any other matters that need to be specified:
    This patent is to protect one of the APIs in the new drug Fespixon cream (Research code: ON101) formulation, which is part of global patent protection of Fespixon cream. No generic manufacturing of the active fraction of Plectranthus amboinicus will be allowed.